Publications by authors named "Ariff Bongso"

Purpose: Previous studies have suggested the involvement of serum insulin-like growth factors (IGFs) and IGF binding proteins (IGFBPs) in the regulation of the female reproductive system. Little is known of these peptides in the seminal plasma (SP) of men and their potential effects on fertility. We assessed SP levels of these peptides in infertile men with low sperm motility (asthenozoospermic; AZ) and low sperm counts (oligozoospermic; OZ), its effects on in vivo sperm motility, and whether there is a correlation with aging.

View Article and Find Full Text PDF

Background: The transplantation of human umbilical cord blood (UCB) CD34+ cells has been successfully used to treat hematological disorders but one major limitation has been the low cell numbers available. Mesenchymal stem cells (MSCs) lying within the bone marrow in vivo behave like a scaffold on which CD34+ cells interact and proliferate. We therefore evaluated the use of allogeneic MSCs from the human UC Wharton's jelly (hWJSCs) as stromal support for the ex vivo expansion of CD34+ cells.

View Article and Find Full Text PDF

Gestational diabetes mellitus (GDM) has been strongly associated with an increased risk of type 2 diabetes mellitus (T2DM) in later child and adulthood. The human umbilical cord and its contents are of fetal origin and represent the fetus genetically and physiologically. Since it is not possible to obtain tissues from the fetus and newborn to investigate the association between GDM and later T2DM, we reprogrammed the stem cells from the Wharton's jelly of umbilical cords (hWJSCs) of GDM and non-GDM mothers into induced pluripotent stem cells (iPSCs) and then differentiated the iPSCs into insulin-producing cells (IPCs) to provide pancreatic tissues that represent the fetus of GDM and normal mothers.

View Article and Find Full Text PDF

Mesenchymal stem cells from Wharton's jelly of the human umbilical cord (hWJSCs), and the conditioned medium (hWJSC-CM) prepared from them, were shown to be tumoricidal on many cancers. However, these tumoricidal effects were observed in hWJSCs grown under normoxic conditions of 21% oxygen in the laboratory. Since oxygen concentrations in the stem cell niche or physiological microenvironment are hypoxic and help to maintain stemness properties, the objective of this work was to evaluate whether there were differences in the tumoricidal properties of hWJSC-CM grown in 21% O (normoxic) or 5% O (hypoxic) environments.

View Article and Find Full Text PDF

Background: Keloid formation occurs in Caucasian, African, and Asian populations and is a severe psychosocial burden on patients. There is no permanent treatment for this problem as its pathogenesis is not properly understood. Furthermore, differences in keloid behavior between ethnic groups are not known.

View Article and Find Full Text PDF

Background: Human Wharton's jelly-derived mesenchymal stromal cells (hWJSCs) have gained considerable attention for their use in cell therapy. Many of these applications would require manufacturing of millions of hWJSCs. It is, therefore, necessary to develop a Good Manufacturing Practice (GMP)-compliant hWJSC expansion protocol, allowing the generation of a large quantity of cells to meet both clinical and regulatory requirements.

View Article and Find Full Text PDF

We showed in previous studies that human umbilical cord Wharton's jelly stem cells (hWJSCs) improved the healing rates of excisional and diabetic wounds in the mouse model. As an extension of those studies, we report here the more detailed quantitative histological, immunohistochemical, and genomic evaluation of biopsies from those excisional and diabetic wounds in an attempt to understand the mechanisms of the enhanced wound healing aided by hWJSCs. Bright-field microscopic observations and ImageJ software analysis on histological sections of the excisional and diabetic wound biopsies collected at different time points showed that the thickness of the epidermis and dermis, and positive picrosirius-red stained areas for collagen, were significantly greater in the presence of hWJSCs compared with controls (P < 0.

View Article and Find Full Text PDF

Gestational diabetes mellitus (GDM) has been associated with an increased risk of maternal and neonatal morbidity. The Wharton's jelly (WJ) of the umbilical cord (UC) is a useful indicator of the deleterious effects of hyperglycemia on fetal tissues as it represents the fetus embryologically, physiologically and genetically. We studied WJ mesenchymal stem cells (hWJSCs) from UC from mothers without GDM (Normal; n = 3); insulin-controlled GDM mothers (GDMi; n = 3) and diet-controlled GDM mothers (GDMd; n = 3)].

View Article and Find Full Text PDF
Article Synopsis
  • Human Wharton's jelly stem cells (hWJSCs) from umbilical cords are a promising alternative to bone marrow stem cells (hBMMSCs) due to their unique properties, such as high proliferation rate and extensive differentiation potential.
  • A study using single-cell RNA sequencing revealed 436 genes with different expression levels between hWJSCs and hBMMSCs, indicating roles in critical processes like wound healing and immune response.
  • Understanding these gene expression differences could enhance clinical applications of hWJSCs and lead to new therapeutic methods.
View Article and Find Full Text PDF

The maintenance of appropriate arterial tone is critically important for normal physiological arterial function. However, the cellular and molecular mechanisms remain poorly defined. Here, we have shown that in the mouse aorta, resident macrophages prevented arterial stiffness and collagen deposition in the steady state.

View Article and Find Full Text PDF

Objective: Human primitive erythroblasts produced during early embryogenesis have been found in maternal circulation at early gestation and are considered good target cells for noninvasive prenatal diagnosis. We aimed to gain a better understanding of the biology of primitive erythroblasts and maximize their potential utility for noninvasive prenatal diagnosis.

Methods: Cells were obtained from first trimester human placental tissues.

View Article and Find Full Text PDF

Strategies that induce immunogenic cell death (ICD) or downregulate CD47 or PD-L1 expression have resulted in successful therapeutic options for tumor eradication. Several groups have reported the tumoricidal effects of human umbilical cord Wharton's jelly stem cells (hWJSCs) or its conditioned medium (hWJSC-CM) on certain cancers but the mechanisms have not been elucidated. Since hWJSCs possess immunomodulatory properties, we investigated whether one of the tumoricidal mechanisms was via ICD.

View Article and Find Full Text PDF

The infants of mothers with gestational diabetes mellitus (GDM) have an increased risk of metabolic and cardiovascular disease. It has been difficult to study the direct effects of maternal hyperglycemia on the fetus because of inaccessibility of fetal tissues. The development of tissues that simulate the function of fetal organs using stem cell technology provides an unprecedented opportunity to study this disorder.

View Article and Find Full Text PDF
Article Synopsis
  • Research focused on how hWJSCs affected lymphoma cells revealed that a specific 3 kDa concentrate from hWJSCs resulted in increased hydrogen peroxide levels, leading to cell death and apoptosis.
  • The findings suggest that manipulating hydrogen peroxide levels through hWJSCs could be a potential strategy for developing new treatments for lymphoma.
View Article and Find Full Text PDF

Some cord blood banks freeze entire pieces of UC (mixed cord, MC) which after post-thaw yields mixed heterogeneous populations of mesenchymal stem cells (MSCs) from all its microanatomical compartments. Freezing of such entire tissues results in sub-optimal post-thaw cell recovery because of poor cryoprotectant diffusion and intracellular ice-formation, heat and water transport issues, and damage to intercellular junctions. To develop a simple method of harvesting pure homogeneous MSCs for cord blood banks, we compared the post-thaw behavior of three groups of frozen UC tissues: (i) freshly harvested WJ without cell separation; (ii) MSCs isolated from WJ (WJSC); and (iii) MC, WJ, and WJSC produced high post-thaw cell survival rates (93.

View Article and Find Full Text PDF

The human umbilical cord (UC) is an attractive source of mesenchymal stem cells (MSCs) with unique advantages over other MSC sources. They have been isolated from different compartments of the UC but there has been no rigorous comparison to identify the compartment with the best clinical utility. We compared the histology, fresh and cultured cell numbers, morphology, proliferation, viability, stemness characteristics and differentiation potential of cells from the amnion (AM), subamnion (SA), perivascular (PV), Wharton's jelly (WJ) and mixed cord (MC) of five UCs.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers found that primitive mesenchymal stem cells from the umbilical cord (hWJSCs) can kill solid tumors, suggesting they might protect fetuses from cancer during pregnancy.
  • The study specifically examined if hWJSCs can also inhibit non-solid tumors like Burkitt's lymphoma and found that they significantly reduce the growth of these cancer cells in lab tests.
  • The proposed mechanism for this inhibition involves hWJSCs triggering oxidative stress in the lymphoma cells, leading to their death and subsequent removal by the hWJSCs themselves.
View Article and Find Full Text PDF
Article Synopsis
  • * Research indicates that human Wharton's jelly stem cells (hWJSCs), which release beneficial cytokines, can inhibit keloid cell growth in lab settings, suggesting a possible treatment approach.
  • * Treatment with hWJSCs leads to decreased keloid cell proliferation and changes in gene expression related to cell growth, death, and autophagy, highlighting their therapeutic potential.
View Article and Find Full Text PDF

Wound healing is a major problem in diabetic patients and current methods of treatment have met with limited success. Since skin cell renewal is under the control of mesenchymal stem cells (MSCs) treatment of wounds has been attempted with the application of exogenous bone marrow MSCs (hBMMSCs). However, hBMMSCs have the limitations of painful harvest, low cell numbers and short-lived stemness properties unlike MSCs from the Wharton's jelly of human umbilical cords (hWJSCs).

View Article and Find Full Text PDF
Article Synopsis
  • Diabetic patients often struggle with wound healing, and current treatments have limited effectiveness, prompting the exploration of an alternative treatment using stem cells from human umbilical cord Wharton's jelly (hWJSCs).
  • hWJSCs have advantageous properties such as being non-controversial, available, and promoting tissue repair by differentiating into keratinocytes and secreting beneficial molecules, leading to improved healing outcomes in wound assays and murine models.
  • Treatment with hWJSCs or their conditioned medium resulted in significantly faster healing rates, increased cell migration, and enhanced tissue characteristics, suggesting their potential as an effective solution for managing excisional and diabetic wounds.
View Article and Find Full Text PDF

Stem cells isolated from the Wharton's jelly of the human umbilical cord (hWJSCs) are unique compared to other stem cell types as they lie in between embryonic stem cells (ESCs) and adult mesenchymal stem cells (MSCs) on the developmental map and share stemness markers of ESCs and MSCs. Yet, they do not induce tumorigenesis and are hypoimmunogenic and proliferative and fresh cell numbers can be harvested painlessly in abundance from discarded umbilical cords. Additionally, they secrete important soluble bioactive molecules from the interleukin and cell adhesion family, hyaluronic acid, collagen, glycosoaminoglycans, and chondroitin sulfate.

View Article and Find Full Text PDF
Article Synopsis
  • Hematopoietic stem cells (HSCs) from umbilical cord blood can treat blood disorders, but limited cell doses pose a challenge for effective treatment, particularly in double cord blood transplants where one unit often dominates.
  • A new freezing protocol combining slow freezing and a specialized medium (DMSO, FBS, and hWJSC-CM) improves the survival rate and quantity of CD34+ cells after thawing, showing significant increases in cell viability and colony formation.
  • The enhancements are likely due to high levels of beneficial substances in the hWJSC-CM that protect cells during freezing and promote their growth post-thaw, suggesting it could be a valuable addition for cord blood banks.
View Article and Find Full Text PDF